Role of tumor–host interactions in interstitial diffusion of macromolecules: cranial vs. subcutaneous tumors A Pluen, Y Boucher, S Ramanujan, TD McKee, T Gohongi, E Di Tomaso, ... Proceedings of the National Academy of Sciences 98 (8), 4628-4633, 2001 | 710 | 2001 |
In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy EB Brown, RB Campbell, Y Tsuzuki, L Xu, P Carmeliet, D Fukumura, ... Nature medicine 7 (7), 864-868, 2001 | 706 | 2001 |
Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors RB Campbell, D Fukumura, EB Brown, LM Mazzola, Y Izumi, RK Jain, ... Cancer research 62 (23), 6831-6836, 2002 | 457 | 2002 |
Two-photon fluorescence correlation microscopy reveals the two-phase nature of transport in tumors G Alexandrakis, EB Brown, RT Tong, TD McKee, RB Campbell, ... Nature medicine 10 (2), 203-207, 2004 | 211 | 2004 |
The drug loading, cytotoxicty and tumor vascular targeting characteristics of magnetite in magnetic drug targeting S Dandamudi, RB Campbell Biomaterials 28 (31), 4673-4683, 2007 | 152 | 2007 |
Influence of cationic lipids on the stability and membrane properties of paclitaxel‐containing liposomes RB Campbell, SV Balasubramanian, RM Straubinger Journal of pharmaceutical sciences 90 (8), 1091-1105, 2001 | 148 | 2001 |
PTEN enters the nucleus by diffusion F Liu, S Wagner, RB Campbell, JA Nickerson, CA Schiffer, AH Ross Journal of cellular biochemistry 96 (2), 221-234, 2005 | 140 | 2005 |
Tumor physiology and delivery of nanopharmaceuticals RB Campbell Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2006 | 139 | 2006 |
Phospholipid-cationic lipid interactions: influences on membrane and vesicle properties RB Campbell, SV Balasubramanian, RM Straubinger Biochimica et Biophysica Acta (BBA)-Biomembranes 1512 (1), 27-39, 2001 | 126 | 2001 |
Brain delivery of proteins by the intranasal route of administration: a comparison of cationic liposomes versus aqueous solution formulations MM Migliore, TK Vyas, RB Campbell, MM Amiji, BL Waszczak Journal of pharmaceutical sciences 99 (4), 1745-1761, 2010 | 124 | 2010 |
Fighting cancer: from the bench to bedside using second generation cationic liposomal therapeutics RB Campbell, B Ying, GM Kuesters, R Hemphill Journal of pharmaceutical sciences 98 (2), 411-429, 2009 | 123 | 2009 |
Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson’s disease MM Migliore, R Ortiz, S Dye, RB Campbell, MM Amiji, BL Waszczak Neuroscience 274, 11-23, 2014 | 103 | 2014 |
Drug delivery formulations and targeting RB Campbell, RK Jain US Patent 6,680,068, 2004 | 85 | 2004 |
Development and characterization of magnetic cationic liposomes for targeting tumor microvasculature S Dandamudi, RB Campbell Biochimica et Biophysica Acta (BBA)-Biomembranes 1768 (3), 427-438, 2007 | 83 | 2007 |
Mucin impedes cytotoxic effect of 5-FU against growth of human pancreatic cancer cells: overcoming cellular barriers for therapeutic gain AV Kalra, RB Campbell British journal of cancer 97 (7), 910-918, 2007 | 67 | 2007 |
Conjugation of bevacizumab to cationic liposomes enhances their tumor-targeting potential GM Kuesters, RB Campbell Nanomedicine 5 (2), 181-192, 2010 | 62 | 2010 |
Battling tumors with magnetic nanotherapeutics and hyperthermia: turning up the heat RB Campbell Future Medicine Ltd 2 (5), 649-652, 2007 | 62 | 2007 |
Importance of the liposomal cationic lipid content and type in tumor vascular targeting: physicochemical characterization and in vitro studies using human primary and … S Dabbas, RR Kaushik, S Dandamudi, GM Kuesters, RB Campbell Endothelium 15 (4), 189-201, 2008 | 61 | 2008 |
Mucin overexpression limits the effectiveness of 5-FU by reducing intracellular drug uptake and antineoplastic drug effects in pancreatic tumours AV Kalra, RB Campbell European Journal of Cancer 45 (1), 164-173, 2009 | 60 | 2009 |
Development of 5-FU and doxorubicin-loaded cationic liposomes against human pancreatic cancer: Implications for tumor vascular targeting AV Kalra, RB Campbell Pharmaceutical research 23, 2809-2817, 2006 | 54 | 2006 |